These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33238207)

  • 1. Ocular surface complications of local anticancer drugs for treatment of ocular tumors.
    Moon J; Choi SH; Lee MJ; Jo DH; Park UC; Yoon SO; Woo SJ; Oh JY
    Ocul Surf; 2021 Jan; 19():16-30. PubMed ID: 33238207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of anticancer drugs on the ocular surface.
    Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K
    Ocul Surf; 2020 Jul; 18(3):403-417. PubMed ID: 32344148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
    Agustoni F; Platania M; Vitali M; Zilembo N; Haspinger E; Sinno V; Gallucci R; de Braud F; Garassino MC
    Cancer Treat Rev; 2014 Feb; 40(1):197-203. PubMed ID: 23850197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular toxicity and cancer chemotherapy. A review.
    al-Tweigeri T; Nabholtz JM; Mackey JR
    Cancer; 1996 Oct; 78(7):1359-73. PubMed ID: 8839540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular surface toxicities associated with modern anticancer therapies.
    Boucher R; Haigh O; Barreau E; Champiat S; Lambotte O; Adam C; Labetoulle M; Rousseau A
    Surv Ophthalmol; 2024; 69(2):198-210. PubMed ID: 37806566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Surface Side Effects of Novel Anticancer Drugs.
    Vitiello L; Lixi F; Coco G; Giannaccare G
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Significance of the Ocular Adverse Effect Induced by Systemic Taxane Application.
    Ye YT; Zhou ZY; Wen LS; Sun Y; Chu ZJ; Dou GR
    Front Biosci (Landmark Ed); 2022 May; 27(6):171. PubMed ID: 35748247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular side effects of cancer chemotherapy.
    Vizel M; Oster MW
    Cancer; 1982 May; 49(10):1999-2002. PubMed ID: 7074524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular toxicity of systemic anticancer chemotherapy.
    Omoti AE; Omoti CE
    Pharm Pract (Granada); 2006 Apr; 4(2):55-9. PubMed ID: 25247000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
    Kunkler AL; Binkley EM; Mantopoulos D; Hendershot AJ; Ohr MP; Kendra KL; Davidorf FH; Cebulla CM
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1771-1781. PubMed ID: 31098752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-Drug Conjugates and Ocular Toxicity.
    Jaffry M; Choudhry H; Aftab OM; Dastjerdi MH
    J Ocul Pharmacol Ther; 2023 Dec; 39(10):675-691. PubMed ID: 37615544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Toxicity of Tyrosine Kinase Inhibitors.
    Davis ME
    Oncol Nurs Forum; 2016 Mar; 43(2):235-43. PubMed ID: 26906134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular toxicity of targeted therapies.
    Renouf DJ; Velazquez-Martin JP; Simpson R; Siu LL; Bedard PL
    J Clin Oncol; 2012 Sep; 30(26):3277-86. PubMed ID: 22649132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal Marginal Zone B-cell Lymphoma of the Ocular Adnexa.
    Guffey Johnson J; Terpak LA; Margo CE; Setoodeh R
    Cancer Control; 2016 Apr; 23(2):140-9. PubMed ID: 27218791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular disorders of anticancer drugs--ocular side effects].
    Kashiwagi H
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1639-44. PubMed ID: 20841924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular toxicities associated with antibody drug conjugates and immunotherapy in oncology: clinical presentation, pathogenesis, and management strategies.
    Raheem F; Alsuhebany N; Hickey Zacholski E; Paulic N; Sandler A; Uk N; Moore DC
    Expert Opin Drug Saf; 2023; 22(10):921-928. PubMed ID: 37612255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.
    Ng CY; Chen CB; Wu MY; Wu J; Yang CH; Hui RC; Chang YC; Lu CW
    J Immunol Res; 2018; 2018():5376476. PubMed ID: 29577050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy-induced toxicity.
    Rühle A; Huber PE; Saffrich R; Lopez Perez R; Nicolay NH
    Int J Cancer; 2018 Dec; 143(11):2628-2639. PubMed ID: 29931767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.